Last updated: 17 June 2024 at 6:58pm EST

Muna Bhanji Net Worth




The estimated Net Worth of Muna Bhanji is at least $1.27 Million dollars as of 10 June 2024. Muna Bhanji owns over 3,870 units of Veracyte Inc stock worth over $700,544 and over the last 4 years Muna sold VCYT stock worth over $569,948.

Muna Bhanji VCYT stock SEC Form 4 insiders trading

Muna has made over 9 trades of the Veracyte Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Muna sold 3,870 units of VCYT stock worth $78,638 on 10 June 2024.

The largest trade Muna's ever made was selling 5,893 units of Veracyte Inc stock on 16 June 2023 worth over $155,811. On average, Muna trades about 641 units every 13 days since 2021. As of 10 June 2024 Muna still owns at least 23,105 units of Veracyte Inc stock.

You can see the complete history of Muna Bhanji stock trades at the bottom of the page.



What's Muna Bhanji's mailing address?

Muna's mailing address filed with the SEC is C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM, MA, 02451.

Insiders trading at Veracyte Inc

Over the last 11 years, insiders at Veracyte Inc have traded over $201,983,044 worth of Veracyte Inc stock and bought 75,122 units worth $1,149,322 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Nicole Vitullo, and Jesse I Treu. On average, Veracyte Inc executives and independent directors trade stock every 20 days with the average trade being worth of $804,905. The most recent stock trade was executed by John Leite on 4 September 2024, trading 5,479 units of VCYT stock currently worth $163,165.



What does Veracyte Inc do?

veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .



What does Veracyte Inc's logo look like?

Veracyte Inc logo

Complete history of Muna Bhanji stock trades at Ardelyx Inc, Cytokinetics Inc, Intellia Therapeutics Inc, and Veracyte Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
10 Jun 2024 Muna Bhanji
Director
Sale 3,870 $20.32 $78,638
10 Jun 2024
23,105
28 May 2024 Muna Bhanji
Director
Sale 1,539 $21.00 $32,319
28 May 2024
26,975
16 Jun 2023 Muna Bhanji
Director
Sale 5,893 $26.44 $155,811
16 Jun 2023
28,514
30 May 2023 Muna Bhanji
Director
Sale 1,539 $25.91 $39,875
30 May 2023
24,733
10 Jun 2024 Muna Bhanji
Director
Sale 2,000 $52.07 $104,140
10 Jun 2024
17,631
7 Jul 2023 Muna Bhanji
Director
Sale 2,000 $34.12 $68,240
7 Jul 2023
14,031
31 Oct 2023 Muna Bhanji
Sale 265 $23.90 $6,334
31 Oct 2023
11,996
31 Jul 2023 Muna Bhanji
Sale 265 $42.33 $11,217
31 Jul 2023
12,261
6 Jul 2023 Muna Bhanji
Sale 1,867 $39.30 $73,373
6 Jul 2023
12,526


Veracyte Inc executives and stock owners

Veracyte Inc executives and other stock owners filed with the SEC include: